Counterforce Health Team

Counterforce Health Team

How to Get Orfadin (nitisinone) Covered by Aetna CVS Health in North Carolina: Complete PA Guide with Appeals Timeline

Answer Box: Getting Orfadin (nitisinone) Covered by Aetna CVS Health in North Carolina Aetna CVS Health requires prior authorization for Orfadin (nitisinone) with approval contingent on confirmed hereditary tyrosinemia type 1 (HT-1) diagnosis, elevated succinylacetone levels, and documented dietary management. Standard decisions take 72 hours; expedited requests get 24-hour responses.
5 min read

How to Get Hetlioz (Tasimelteon) Covered by Humana in Florida: Prior Authorization Forms, Appeals Process, and Medical Necessity Requirements

Quick Answer: Hetlioz (tasimelteon) requires prior authorization from Humana Medicare plans in Florida. Submit PA request through CenterWell Specialty Pharmacy with documented Non-24-Hour Sleep-Wake Disorder diagnosis, sleep logs, and failed conservative therapies. Standard approval takes 7-30 days; expedited review available if delay risks health. Appeals must be filed within 65
6 min read

How to Renew Brensocatib (BRINSUPRI) Approval with Humana in Virginia: 2025 Timeline & Required Documentation

Answer Box: Renewing Brensocatib (BRINSUPRI) with Humana in Virginia Brensocatib (BRINSUPRI) renewal with Humana typically requires submission 30-60 days before your current authorization expires. Key requirements: documented adherence ≥85%, clinical response evidence (reduced exacerbations, stable/improved FEV1), and prescriber attestation of continued medical necessity. Submit renewal requests via Humana'
4 min read

Jakafi (Ruxolitinib) Approval with UnitedHealthcare in New York: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Jakafi (Ruxolitinib) Covered by UnitedHealthcare in New York Jakafi (ruxolitinib) requires prior authorization through OptumRx for most UnitedHealthcare plans in New York. Your fastest path to approval: (1) Have your hematologist/oncologist gather diagnosis confirmation (bone marrow biopsy, JAK2 mutation), recent labs (CBC with platelets ≥50,000/
6 min read